Trial
NCT06165809
A Clinical Trial of TQB3015 Tablets in Patients With Advanced Malignant Cancer
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Collaborators
—
Condition
Advanced Malignant Neoplasm
Intervention
TQB3015 tablets
Why stopped
The sponsor voluntarily withdraw the project.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-12-29